Legislation Would Provide Medicare Coverage for Pharmacy-Based Testing

Recently introduced federal legislation would provide Medicare coverage for a variety of pharmacy services including diagnostic testing.

Called the Equitable Community Access to Pharmacist Services Act, the bill would establish Medicare Part B coverage for pharmacy testing for diseases including COVID-19, flu, respiratory syncytial virus, and strep throat as well as other conditions identified in the future by the Department of Health and Human Services as necessary to close “gaps in health equity.”

The bill would also provide Medicare coverage for pharmacy services including treatments and vaccinations for diseases including COVID-19, flu, and strep throat. Pharmacists would be reimbursed for these services at 85 percent of the physician fee schedule.

Source: https://www.360dx.com/diagnostics/legislation-would-provide-medicare-coverage-pharmacy-based-testing